Luke Nathaniel Walker - 12 Jun 2025 Form 4 Insider Report for Context Therapeutics Inc. (CNTX)

Role: Director
Signature: /s/ Alex Levit, Attorney-in-Fact
Issuer symbol: CNTX
Transactions as of: 12 Jun 2025
Net transactions value: $0
Form type: 4
Filing time: 12 Jun 2025, 17:24:53 UTC
Previous filing: 04 Feb 2025
Next filing: 18 Jun 2025
SEC: View on sec.gov

Reporting Owners (1)

Name	Relationship	Address	Signature	Signature date	CIK
Walker Luke Nathaniel	Director	2001 MARKET STREET, SUITE 3915 UNIT #15, PHILADELPHIA	/s/ Alex Levit, Attorney-in-Fact	12 Jun 2025	0001701440

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	CNTX	Stock Option (right to buy)	Award	$0	+123,500		$0.000000	123,500	12 Jun 2025	Common Stock	123,500	$0.6530	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The option vests and becomes exercisable on the earlier of (i) June 12, 2026 (the one-year anniversary of the date of grant) or (ii) the Issuer's 2026 annual meeting of stockholders, subject to continued service with the Issuer.